openPR Logo

Press Releases from Oncolytic Virus (2 total)

Analysis Of Oncolytic Virus: Market Landscape, Pipeline, Stakeholders, Deals, In …

Researchmoz added Most up-to-date research on "Analysis Of Oncolytic Virus: Market Landscape, Pipeline, Stakeholders, Deals, Industry Trends & Opportunities To 2017" to its huge collection of research reports. The field of oncolytic viruses was quite dormant in the first decade of the 2000s, characterized by slow clinical progress due to hypercautiousness and low, albeit steady, investments. The takeover of BioVex by Amgen in late 2011, worth up to US$ 1 bln,

The Oncolytic Virus Landscape 2017: An Analysis Of Pipeline, Stakeholders, Deals …

The field of oncolytic viruses was quite dormant in the first decade of the 2000s, characterized by slow clinical progress due to hypercautiousness and low, albeit steady, investments. The takeover of BioVex by Amgen in late 2011, worth up to US$ 1 bln, has woken up the field and became a game changer together with the 2015 approval of the first oncolytic virus Imlygic developed by BioVex in regulated markets.

Go To Page:   1 2 3 4 5 6 7 8 9 10